VC  Galen Partners

http://www.galen.com





     Office Locations:

680 Washington Boulevard, 10th Floor
Stamford, CT 06901
Phone: 203-653-6400
Fax: 203-653-6499

 

Stages:

  • Expansion
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Galen Partners is a Stamford-based, private equity firm focused on healthcare information technology/outsourcing, medical devices and specialty pharmaceutical companies. The firm recently raised $250 million for its fifth investment fund. Since 1990, Galen has built an investment portfolio with an aggregate market value of over $10 billion-and helped 70 of its portfolio companies navigate through the paths of public offerings, debt financings, and mergers and acquisitions. The firm typically invests $15 to $25 million in transactions, with a minimum initial investment of $10 million, but has led transactions requiring upwards of $100 million of equity. Galen seeks to invest in healthcare growth equity companies with proprietary products or services that have attained a revenue run-rate above $10 million and have near-term prospects for positive cash flow. Galen currently has nearly $1 billion under management.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bill Williams Special Venture Partner
    Bruce Wesson Founding Partner Emeritus and Senior Advisor
    David Jahns Managing Partner
    Judith Starkey Special Investment Partner
    Ken Davidson Special Investment Partner

     

    Portfolio companies include:


      Acura Pharmaceuticals
        web link


      Aperio
        web link


      Cambrooke Foods
        web link


      Cambrooke Therapeutics
        web link


      Cardiva
        web link


      Dakim
        web link


      Derma Sciences
        web link


      EchoServe
        web link


      Integrated Diagnostic Centers
        web link


      International Medical Group
        web link


      InTouch Health
        web link


      LifeImage
        web link


      MedAssets
        web link


      National Rehab Equipment
        web link


      Nautilus Neurosciences
        web link


      ONI Medical Systems
        web link


      PeriGen
        web link


      Quotient Biodiagnostics Holdings
        web link


      Sharecare
        web link


      SonaCare Medical
        web link


      Soteira
        web link


      Tactile Systems Technology
        web link


      Tech Pharmacy Services
        web link


      Unisyn Medical Technologies
        web link


      USHIFU
        web link


     

    Recent News: